Gunzburg allowed an increase in the interval between the introduction of Sputnik V components

“With regard to the Sputnik V vaccine developed at our center named after

N.F.

Gamaleya, at the request of foreign partners, we inform you that we consider it possible, at their request, in foreign markets to increase the minimum interval between the introduction of the first and second components of the vaccine from the previously approved 21 days for up to three months, "Ginzburg said in a statement published on the Telegram channel. "Sputnik V".

“This increase in the interval will not affect the strength of the immune response caused by our vaccine, but in some cases will increase and prolong it,” explained Gunzburg.

Earlier it was reported that the Russian Direct Investment Fund (RDIF) and the Turkish pharmaceutical company VisСoran İlaç announced cooperation for the production of the Russian vaccine against coronavirus Sputnik V in Turkey.